<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Urethral stenosis &#8211; European Clinical Trials Information Network</title>
	<atom:link href="https://clinicaltrials.eu/meddra_pt/urethral-stenosis/feed/" rel="self" type="application/rss+xml" />
	<link>https://clinicaltrials.eu</link>
	<description>Bridging Patients with Clinical Trials</description>
	<lastBuildDate>Fri, 12 Jun 2026 10:37:24 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png</url>
	<title>Urethral stenosis &#8211; European Clinical Trials Information Network</title>
	<link>https://clinicaltrials.eu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Study on the Safety of Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells for Patients with Recurrent Urethral Stricture</title>
		<link>https://clinicaltrials.eu/trial/study-on-the-safety-of-autologous-adipose-tissue-derived-stromal-vascular-fraction-cells-for-patients-with-recurrent-urethral-stricture/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Wed, 29 Apr 2026 15:01:21 +0000</pubDate>
				<guid isPermaLink="false">https://clinicaltrials.eu/trial/study-on-the-safety-of-autologous-adipose-tissue-derived-stromal-vascular-fraction-cells-for-patients-with-recurrent-urethral-stricture/</guid>

					<description><![CDATA[This clinical trial is focused on studying the condition known as urethral stricture, which is a narrowing of the urethra that can cause problems with urination. The study is investigating a new treatment approach that involves the use of stromal vascular fraction cells derived from a patient&#8217;s own fat tissue. These cells are injected as [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>This clinical trial is focused on studying the condition known as <u>urethral stricture</u>, which is a narrowing of the urethra that can cause problems with urination. The study is investigating a new treatment approach that involves the use of <u>stromal vascular fraction cells</u> derived from a patient&#8217;s own fat tissue. These cells are injected as an additional treatment alongside a procedure called <u>endoscopic urethrotomy</u>, which is a surgical method used to treat the narrowing of the urethra.</p>
<p>The purpose of the study is to evaluate the safety and potential benefits of this innovative treatment. Participants in the study will receive either the new cell-based treatment or a placebo, in addition to the standard surgical procedure. The treatment involves injecting the cells under the skin, and the study will monitor participants over a period of time to assess any side effects and improvements in symptoms.</p>
<p>Throughout the study, participants will undergo various assessments, including questionnaires about their symptoms and quality of life, as well as tests like <u>uroflowmetry</u> to measure urine flow and <u>MRI</u> scans to evaluate changes in the urethra. The study aims to provide valuable information on whether this new treatment can help improve outcomes for patients with urethral stricture.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
